Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 13.7 USD -1.23% Market Closed
Market Cap: 973.4m USD
Have any thoughts about
Zymeworks Inc?
Write Note

Relative Value

The Relative Value of one ZYME stock under the Base Case scenario is 16.3 USD. Compared to the current market price of 13.7 USD, Zymeworks Inc is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZYME Relative Value
Base Case
16.3 USD
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
48
Median 3Y
11.8
Median 5Y
14.7
Industry
8.1
Forward
8.7
vs History
vs Industry
11
Median 3Y
-1.7
Median 5Y
-6.4
Industry
23.9
Forward
-12.1
vs History
vs Industry
14
Median 3Y
-2
Median 5Y
-6.6
Industry
22.7
vs History
vs Industry
10
Median 3Y
-1.8
Median 5Y
-7.5
Industry
26.3
vs History
49
vs Industry
52
Median 3Y
1.5
Median 5Y
2.3
Industry
2.6
vs History
46
vs Industry
57
Median 3Y
4.5
Median 5Y
9.5
Industry
8
Forward
5.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
13
Median 3Y
-0.7
Median 5Y
-3.5
Industry
4.5
Forward
-4.8
vs History
vs Industry
12
Median 3Y
-0.7
Median 5Y
-3.3
Industry
4.1
Forward
-5.6
vs History
vs Industry
15
Median 3Y
-0.7
Median 5Y
-3.4
Industry
6.1
vs History
vs Industry
11
Median 3Y
-0.7
Median 5Y
-4.1
Industry
3.8
vs History
46
vs Industry
50
Median 3Y
1.3
Median 5Y
2.8
Industry
4.8

Multiples Across Competitors

ZYME Competitors Multiples
Zymeworks Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Zymeworks Inc
NASDAQ:ZYME
970.4m USD 15.6 -8.7 -5.8 -5.3
US
Abbvie Inc
NYSE:ABBV
358.9B USD 6.5 68 16.5 25.2
US
Amgen Inc
NASDAQ:AMGN
172.7B USD 5.6 55.2 19.5 35.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
122.8B USD 11.9 -250.7 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
110.7B USD 4 105.2 9.9 12.6
US
Epizyme Inc
F:EPE
94.1B EUR 1 932.8 -493.2 -537.1 -522.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
92B USD 6.8 21.3 18.2 20.2
AU
CSL Ltd
ASX:CSL
138.7B AUD 6.2 34.5 21.2 26.5
US
Seagen Inc
F:SGT
39.3B EUR 18.6 -57.1 -61.4 -55.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
34.2B USD 14.6 -469.3 206.3 317.6
NL
argenx SE
XBRU:ARGX
32B EUR 17.9 -125.6 -100.7 -73.4
P/E Multiple
Earnings Growth
US
Zymeworks Inc
NASDAQ:ZYME
Average P/E: 56.8
Negative Multiple: -8.7
N/A
US
Abbvie Inc
NYSE:ABBV
68
406%
US
Amgen Inc
NASDAQ:AMGN
55.2
74%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
105.2
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493.2 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
21.3
56%
AU
CSL Ltd
ASX:CSL
34.5
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -469.3 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -125.6 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Zymeworks Inc
NASDAQ:ZYME
Average EV/EBITDA: 45.5
Negative Multiple: -5.8
N/A
US
Abbvie Inc
NYSE:ABBV
16.5
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
64%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
37%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
9%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -537.1 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.2
53%
AU
CSL Ltd
ASX:CSL
21.2
42%
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
206.3
N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -100.7 N/A
EV/EBIT Multiple
EBIT Growth
US
Zymeworks Inc
NASDAQ:ZYME
Average EV/EBIT: 66.5
Negative Multiple: -5.3
N/A
US
Abbvie Inc
NYSE:ABBV
25.2
88%
US
Amgen Inc
NASDAQ:AMGN
35.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
12.6
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -522.8 N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.2
54%
AU
CSL Ltd
ASX:CSL
26.5
55%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
317.6
N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -73.4 N/A

See Also

Discover More
Back to Top